Global Blood Therapeutics Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (14)

Latest Posts

About This Stock More About This Stock
Global Blood Therapeutics Announces Full Exercise Of Underwriter’s Option To Purchase Additional Shares
Article By: NASDAQ GlobeNewswire
Monday, March 12, 2018 12:45 PM EDT
Global Blood Therapeutics, Inc. today announced that the underwriter of its previously announced underwritten public offering has exercised in full its option to purchase an additional 600,000 shares of GBT’s common stock.
In this article: GBT
Read
Global Blood Therapeutics Announces Proposed Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, March 8, 2018 5:40 PM EDT
Global Blood Therapeutics, Inc. today announced a registered offering of 3,500,000 shares of its common stock.
In this article: GBT
Read
Global Blood Therapeutics Prices A $100.0 Million Common Stock Public Offering
Article By: NASDAQ GlobeNewswire
Friday, December 15, 2017 9:49 AM EDT
Global Blood Therapeutics, Inc. today announced the pricing of its underwritten public offering of its common stock for gross proceeds of approximately $100.0 million.
In this article: GBT
Read
10 Stocks To Soar In 2018
Article By: TipRanks
Wednesday, December 13, 2017 2:18 PM EDT
The market is currently trading at record highs, boosted by the prospect of business-friendly tax reforms.
In this article: HRTX, LRCX, MSFT, AVGO, GBT
Read
Week In Review: China Pharma Cross-Border Deals
Article By: ChinaBio® Today
Saturday, January 16, 2016 12:50 PM EDT
BioAtla LLC, a San Diego-Beijing biotech, raised $45 million from the Global BIO Impact Fund, a US bioscience investor. BioAtla will use the capital to develop its portfolio of Conditionally Active Biologic antibody therapeutics.
In this article: AGN, MDT, PFE, GBT
Read

PARTNER HEADLINES

Latest Tweets for $GBT

No tweets yet!